CCL3 and respiratory failure: Interestingly, weight loss is sustained among the mice overexpressing CCL3 while receiving supplemental IFNγ over the 9 day examination period [Figure 5D], but, despite the substantial inflammatory response, we observe no progression to respiratory failure up to and including t = 14 days.